Indication
GCP
2 clinical trials
2 products
Clinical trial
Phase IV Clinical Study on Safety and Efficacy of Quadrivalent Influenza Virus Split Vaccine in Larger PopulationStatus: Completed, Estimated PCD: 2023-01-20
Clinical trial
The Shandong Provincial Center for Disease Control and Prevention, ChinaStatus: Completed, Estimated PCD: 2023-02-06
Product
Influenza Vaccine